International Diabetes News
‘I think about diabetes 'every five minutes' - Slade
When England international Henry Slade takes to the pitch on a match day, his mind is not just on the rugby. He is thinking about his blood sugar levels. “Every five minutes probably, you’re thinking – how is this going to affect me?” Slade is one of a number of high-profile athletes who have type 1 diabetes – an autoimmune condition where the body cannot make a hormone called insulin, which controls blood sugar levels. As a result, insulin needs to be taken daily, either through an injection, or a pump system.
Is RFK Jr right about China's diabetes rate?
The US Health Secretary Robert F. Kennedy Jr is on a mission to make America healthy again. One of his health-promotion ideas is to reduce chronic illness, specifically diabetes. And has part of his campaign he said that: “a typical pediatrician would see one case of diabetes in his lifetime, over a 40 or 50 year career. Today, 1 out of every 3 kids who walks through his office door is prediabetic or diabetic. Twenty years ago, there was no diabetes in China, today 50% of the population is diabetic.
Negative workplace treatment affects 40% of employees living with diabetes
Two-fifths [40%] of employees living with diabetes reported negative treatment in the workplace because of their condition, according to a new global study conducted by the International Diabetes Federation (IDF). To mark World Diabetes Day on 14 November, the Federation is highlighting the stigma, discrimination and lack of structural support that people living with diabetes continue to face at work.
Diabetes now affects 1 in 6 pregnancies: What you need to know
This Friday, for World Diabetes Day, the UN is highlighting how the disease affects pregnancy, in line with this year’s global theme of managing diabetes “across life stages”. The organization has also launched its first-ever global guidelines on how to manage diabetes before, during and after pregnancy. “These guidelines are grounded in the realities of women’s lives and health needs, and provide clear, evidence-based strategies to deliver high-quality care for every woman, everywhere,” said Dr Tedros Adhanom Ghebreyesus, who heads the UN World Health Organization.
Diabetes at Work: Unseen Struggles and Everyday Resilience in LMICs
Globally, an estimated 430 million working-age adults live with diabetes, many of whom reside in LMICs. This year, World Diabetes Day draws attention to the daily struggles faced by people with diabetes in the workplace: stigma, discrimination, exclusion, anxiety, and restricted access to care. The conversation around diabetes and employment is often complex, particularly in LMICs, where informal work, limited institutionalised social support, gendered vulnerabilities, and the burden of unpaid labour create unique and frequently invisible challenges for those managing the condition.
Clinical Trials
Clinical trials are conducted to collect data regarding the safety and efficacy of new drug and device development. There are several steps and stages of approval in the clinical trials process before a drug or device can be sold in the consumer market, if ever.
You can search for some available information on clinical trials
You can search for some available information on clinical trials
This study aims to culturally adapt an existing American Diabetes Association (ADA)-recognized diabetes self-management and support or DSMES (Diabetes Self Management Education Support) program (Project Dulce) and integrate an evidence-based text messaging program (Dulce Digital) for implementation in Filipino Americans (FAs) with type 2 diabetes mellitus (T2DM).
Cholesterol Lowering and Residual Risk in Diabetes, Type 1 (CHORD1)
This is a prospective, interventional, cohort study, meaning that researchers will follow and observe a group of enrolled study participants over a period of time (one to two months) to gather information and record any developments of the outcomes in question.
Precision Dosing of Metformin in Youth With T2D (PRECISE_T2D)
The purpose of this study to compare the typically prescribed dose of metformin (1000mg twice a day) with a higher dose of metformin (1350mg twice a day).
A Study to Better Understand the Role of the Hormones Glucagon and Insulin in the Progression of Diabetes
The purpose of this study is to determine the longitudinal effect of diabetes-associated variation in TCF7L2 on a-cell function and the contribution of a-cell function to longitudinal glucose tolerance and EGP in non-diabetic subjects.
Sources: ClinicalTrials.gov and MayoClinic
You can search for some available information on clinical trials